RESEARCH REVIEW · 17 NOVEMBER 2026
GLOW + KLOW: what’s labelled—and what’s actually known? 🔬
These are multi-ingredient research blends, not single molecules.
Labelled composition
GLOW: BPC-157 10 mg + GHK-Cu 50 mg + TB-500 10 mg.
KLOW: the same labelled components, plus KPV 10 mg.
These are composition statements, not independently verified assay results or instructions for use.
What is being studied?
- BPC-157: a synthetic peptide investigated in tissue-repair research. A rat tendon-cell study reported increased cell movement and outgrowth, but not a direct increase in cell proliferation. That is laboratory evidence—not proof of faster human recovery.
- GHK-Cu: a copper-binding tripeptide studied in connective-tissue biology. Experimental rat wounds showed increased collagen and other matrix components. This does not establish a clinical benefit for either blend.
- KPV: a three-amino-acid peptide studied in inflammatory signalling. Cell and mouse intestinal studies reported changes in inflammatory pathways and experimental inflammation—not demonstrated treatment effects in people.
- TB-500: identity matters. An analytical study identified a short thymosin beta-4 fragment in a TB-500 preparation. Research on the full parent peptide cannot automatically be applied to a fragment or a supplier’s blend.
What is still uncertain?
No controlled human trial of these exact GLOW/KLOW blends was identified in the research checked on 17 November 2026.
Ingredient findings cannot establish the combination’s efficacy, safety, stability or interactions. More ingredients do not prove synergy, and a lack of evidence does not establish safety.
Scientific education only. No personal treatment advice.
Original studies
- Chang et al., 2011 · Rat tendon explants and cultured fibroblasts. Read the BPC-157 study ↗
- Maquart et al., 1993 · Experimental rat wound chambers. Read the GHK-Cu study ↗
- Dalmasso et al., 2008 · Cell experiments and mouse intestinal inflammation models. Read the KPV study ↗
- Esposito et al., 2012 · Analytical identification, not an efficacy trial. Read the TB-500 identity study ↗
These historical studies examine components or chemical identity; they do not validate the exact blends. The dated search finding above does not rule out unpublished research.
